Waterfront Wealth Inc. raised its holdings in Teleflex Incorporated (NYSE:TFX – Free Report) by 22.4% during the 1st quarter, HoldingsChannel.com reports. The fund owned 20,568 shares of the medical technology company’s stock after acquiring an additional 3,769 shares during the quarter. Waterfront Wealth Inc.’s holdings in Teleflex were worth $2,460,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. AQR Capital Management LLC grew its holdings in shares of Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company’s stock worth $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. Abrams Bison Investments LLC purchased a new stake in Teleflex in the third quarter valued at approximately $112,317,000. Norges Bank bought a new stake in Teleflex during the fourth quarter valued at approximately $66,076,000. Wolf Hill Capital Management LP bought a new stake in Teleflex during the fourth quarter valued at approximately $47,405,000. Finally, Capital International Investors purchased a new position in Teleflex in the 3rd quarter worth approximately $44,851,000. Institutional investors own 95.62% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 price target on the stock in a report on Monday, April 13th. Mizuho set a $140.00 target price on shares of Teleflex in a research report on Friday, May 8th. Wells Fargo & Company upped their target price on shares of Teleflex from $130.00 to $138.00 and gave the stock an “equal weight” rating in a research report on Friday, May 8th. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research note on Tuesday, April 28th. Finally, Royal Bank Of Canada upgraded Teleflex from a “sector perform” rating to an “outperform” rating and raised their price target for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Five research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $147.44.
Teleflex Trading Up 2.9%
TFX stock opened at $134.16 on Friday. The company has a market capitalization of $5.94 billion, a PE ratio of -5.88, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82. The company has a debt-to-equity ratio of 0.82, a quick ratio of 2.03 and a current ratio of 2.55. Teleflex Incorporated has a one year low of $100.18 and a one year high of $139.67. The company’s 50 day moving average price is $129.72 and its two-hundred day moving average price is $119.99.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same quarter in the prior year, the company earned $1.44 EPS. The firm’s revenue was up 32.3% on a year-over-year basis. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, analysts predict that Teleflex Incorporated will post 6.7 earnings per share for the current fiscal year.
Teleflex Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.0%. The ex-dividend date was Friday, May 22nd. Teleflex’s dividend payout ratio is presently -5.96%.
Teleflex Profile
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Featured Articles
- Five stocks we like better than Teleflex
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
